New Depakote Birth Defect Warning: Category Change from D to X
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The FDA is finally getting around to advising health care professionals and women that the anti-seizure medication Depakote (generics valproate sodium and related products, valproic acid and divalproex sodium) are contraindicated and should not be taken by pregnant women for the
Read MoreDepakote Linked to Spina Bifida
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. As early as 2006, I have been following the problems associated with Depakote and birth defects. However, a new study has radically changed the risk/benefit profile of this over-prescribed drug. The new study, published in the British Journal of Clinical Pharmacology,
Read MoreDepakote Link to Birth Defects Grows
The news about the association of Depakote and birth defects is not new, but the news keeps getting worse. Depakote is linked to an alarming rate of serious congenital anatomical and cognitive defects, and deaths, in babies with in utero exposure. Depakote is used to treat epilepsy but is also a first-line mood stabilizer for
Read More